Document is current
Any future updates will be listed below
-
Authors
Carr, Prudence R.
Webb, Katherine L.
Neumann, Johannes T.
Thao, Le T. P.
Beilin, Lawrence J.
Ernst, Michael E.
Fitzgibbon, Bernadette
Gasevic, Danijela
Nelson, Mark R.
Newman, Anne B.
Orchard, Suzanne G.
Owen, Alice
Reid, Christopher M.
Stocks, Nigel P.
Tonkin, Andrew M.
Woods, Robyn L.
McNeil, John J.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01038583 at ClinicalTrials.govDocuments that mention this clinical trial
Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older Adults
https://doi.org/10.1161/circoutcomes.124.011719
Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older
https://doi.org/10.1161/circgen.121.003429
Protective lipid-lowering variants in healthy older individuals without coronary heart disease
https://doi.org/10.1136/openhrt-2021-001710
Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial
https://doi.org/10.1136/gutjnl-2020-321585
AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol
https://doi.org/10.1136/bmjopen-2016-013636
CKD Biomarkers, Cognitive Impairment, and Incident Dementia in an Older Healthy Cohort
https://doi.org/10.34067/kid.0005672021
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
https://doi.org/10.1136/heartjnl-2014-306342
Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke
https://doi.org/10.1161/strokeaha.125.054979
Predictive Performance of a Polygenic Risk Score for Incident Ischemic Stroke in a Healthy Older Population
https://doi.org/10.1161/strokeaha.120.033670
Associations of body size with all-cause and cause-specific mortality in healthy older adults
https://doi.org/10.1038/s41598-023-29586-w
Long-Term Blood Pressure Variability and Risk of Cardiovascular Disease Events Among Community-Dwelling Elderly
https://doi.org/10.1161/hypertensionaha.120.16209
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (NE 2165/1-1)
National Health and Medical Research Council (GNT 1136372)
National Health and Medical Research Council (334047, 1127060)
National Institutes of Health (U01AG029824, U19AG062682)
Monash University
Victorian Cancer Agency
- License Information
-
More Information
Article History
Received: 13 July 2022
Accepted: 7 February 2023
First Online: 7 March 2023
Competing interests
: J.T.N. has received honoraria from Roche and Siemens Healthinieers. A.M.T has received honoraria from Amgen, Boehinger-Ingelheim, Merck, Novartis and Pfizer. All other authors declare no conflicts of interest.
